Back to Search
JOSEPH REZA HABIBI MD
MD
Urology Physician
NPI: 1912227471IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
MD28577(ME)0101258323(VA)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
0116022424(VA)
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
PMID 19261739·Am J Physiol Renal Physiol·2009
7-preclinical
Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.
PMID 19246535·Endocrinology·2009
7-preclinical
Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.
PMID 19218503·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.
PMID 19114643·Hypertension·2009
7-preclinical
Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.
PMID 19633211·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
PMID 19609077·Am J Nephrol·2009
7-preclinical
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.
PMID 18424632·Am J Physiol Heart Circ Physiol·2008
7-preclinical
Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.
PMID 18445755·Am J Physiol Endocrinol Metab·2008
7-preclinical
Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
PMID 18460596·Am J Physiol Endocrinol Metab·2008
7-preclinical
Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes.
PMID 18641056·Exp Biol Med (Maywood)·2008
7-preclinical
Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.
PMID 18653711·Endocrinology·2008
4-observational
Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
PMID 18172055·Hypertension·2008
7-preclinical
Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.
PMID 19040593·J Cardiometab Syndr·2008
6-review
Diabetic nephropathy and tubulointerstitial fibrosis in cardiometabolic syndrome and type 2 diabetes mellitus.
PMID 17684466·J Cardiometab Syndr·2007
5-case
Ultrastructural islet study of early fibrosis in the Ren2 rat model of hypertension. Emerging role of the islet pancreatic pericyte-stellate cell.
PMID 17993725·JOP·2007
7-preclinical
Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat.
PMID 17032939·Am J Physiol Renal Physiol·2007
7-preclinical
Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
PMID 17204833·Am J Nephrol·2007
7-preclinical
Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
PMID 17317778·Endocrinology·2007
7-preclinical
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
PMID 17440033·Am J Physiol Endocrinol Metab·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3 GLEN COVE DR STE 3
ROCKPORT, ME 04856 - Phone
- (207) 301-5400
Quick Facts
- NPI
- 1912227471
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile